The value of radionuclide scintigraphy in patients with non-visualized gallbladders by oral cholecystography.
This study evaluated the clinical usefulness of Tc-99m-PyG cholescintigraphy in patients who had nonvisualization of the gallbladder after OCG. Nineteen patients with non-visualized gallbladder with OCG subsequently had Tc-99m-PyG cholescintigraphy performed. In nine patients the gallbladder visualized, whereas in ten it did not. Statistical analysis of this limited number of patients showed that Tc-99m-PyG cholescintigraphy was able to separate those patients with clinically significant gallbladder disease from those patients without significant gallbladder disease (p less than 0.05).
D002765:Cholecystography; D003657:Decision Making; D003937:Diagnosis, Differential; D005188:False Negative Reactions; D005704:Gallbladder / Q000000981:diagnostic imaging*; D005705:Gallbladder Diseases / Q000000981:diagnostic imaging* / Q000601:surgery; D005971:Glutamates; D006801:Humans; D015609:Organotechnetium Compounds; D011336:Probability; D011730:Pyridoxal / Q000031:analogs & derivatives*; D011877:Radionuclide Imaging; D013667:Technetium
D005971:Glutamates; D015609:Organotechnetium Compounds; C011551:technetium Tc 99m pyridoxylidene glutamate; D011730:Pyridoxal; D013667:Technetium